Emgality® ▼ (galcanezumab)

This information is intended for UK registered healthcare professionals only as a scientific exchange in response to your search for information. Please refer to the link for full prescribing information: Emgality Summary of Product Characteristics (SmPC)

Emgality®▼ (galcanezumab): Travelling with the Device

The following travel guidance applies to patients that use Emgality devices (pre-filled pens and syringes).

Protecting the Device during Travel outside refrigeration

Emgality may be stored unrefrigerated for single period up to 7 days when stored at temperatures up to 30 °C. If the device is stored at a higher temperature or for a longer period it must be discarded.1

The device should not be returned to the refrigerator once it was stored at room temperature. It should be used within the 7 days period.2

While travelling it is recommended the patient carries the medicine with him all times (e.g. plane, car, bus, train, etc.).2

The medicines should never be packed in with checked luggage. It is possible for luggage hold areas to have wide changes in temperatures. These temperatures may become too cold or too hot and this will affect the medicine.2

While travelling it is important to keep the medicine as cool as possible. To store at 2°C to 8°C is the best temperature to protect the medicine. It should not be frozen as this can damage the medicine and the device. It should be stored in the original package in order to protect from light.1

Travel Cooler Bags

Lilly does not provide cooler bags to travel with the device. Please refer to a pharmacist to discuss available equipment suitable to keep the medicine cool while traveling. Lilly does not test, market or sell these products, therefore, we cannot make recommendations.2

If the patient uses a cooler it is important to keep the device away from direct contact with ice, frozen gel packs or freezing temperatures (0°C or below). The medicine shall always be protected from light and freezing temperatures.2

Impact of Altitude

Changes in altitude that may be experienced when travelling do not impact the dose accuracy of the device.2

Airport Screening/X-ray Impact

The screening equipment used at airports (X-rays) are not known to affect the medicine. If preferred, the medicines and supplies can be inspected by hand when the patient goes through security checkpoints, on request.2

Before travelling the patient should check with the airline company to find out what the current travel policies are for travelling with medicine on board the plane. If travelling internationally, the patient should also check with the authorities in the country he plans to visit.2

The patient should talk to his doctor for possible aspects to consider when travelling. The pharmacist is the appropriate contact for questions related to travelling with medicines.

References

1. Emgality [package leaflet]. Eli Lilly Nederland B.V., The Netherlands.

2. Data on file, Eli Lilly and Company and/or one of its subsidiaries.

This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions.

Date of Last Review: February 13, 2019

Contact Lilly

Call or Email us

If you want to ask a Medical Information question or you want to report an adverse event or product complaint you can call us or email us at ukmedinfo@lilly.com

Available Mon - Fri, 8am - 4pm, excluding Bank Holidays

Or you can

Ask us a question Chat with Us If you have a question, you can chat online with a Lilly Medical Information professional.

Submit a question